ID

34408

Descripción

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01241708

Link

https://clinicaltrials.gov/show/NCT01241708

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 1/10/20 1/10/20 -
  3. 5/10/20 5/10/20 - Sarah Riepenhausen
Titular de derechos de autor

GSK group of companies

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Multiple Myeloma NCT01241708

Eligibility Multiple Myeloma NCT01241708

Criteria
Descripción

Criteria

confirmed diagnosis of multiple myeloma with either durie-salmon stage i, ii, or iii or iss stage i, ii or iii, less than 12 months since initiation of systemic therapy
Descripción

ID.1

Tipo de datos

boolean

≥8x106 cd34+cells/kg available in cryopreservation in aliquots appropriate for tandem transplants
Descripción

ID.2

Tipo de datos

boolean

age: 18-75 years at time of transplantation
Descripción

ID.3

Tipo de datos

boolean

kps 70-100%
Descripción

ID.4

Tipo de datos

boolean

recovery from complications of prior therapies
Descripción

ID.5

Tipo de datos

boolean

gender: there is no gender restriction
Descripción

ID.6

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
diagnosis other than multiple myeloma
Descripción

ID.7

Tipo de datos

boolean

chemotherapy or radiotherapy within 8 days of initiating treatment in this study
Descripción

ID.8

Tipo de datos

boolean

prior autologous or allogeneic transplantation (except as enrolled into this study)
Descripción

ID.9

Tipo de datos

boolean

uncontrolled bacterial, viral, fungal or parasitic infections
Descripción

ID.10

Tipo de datos

boolean

Similar models

Eligibility Multiple Myeloma NCT01241708

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
ID.1
Item
confirmed diagnosis of multiple myeloma with either durie-salmon stage i, ii, or iii or iss stage i, ii or iii, less than 12 months since initiation of systemic therapy
boolean
ID.2
Item
≥8x106 cd34+cells/kg available in cryopreservation in aliquots appropriate for tandem transplants
boolean
ID.3
Item
age: 18-75 years at time of transplantation
boolean
ID.4
Item
kps 70-100%
boolean
ID.5
Item
recovery from complications of prior therapies
boolean
ID.6
Item
gender: there is no gender restriction
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
diagnosis other than multiple myeloma
boolean
ID.8
Item
chemotherapy or radiotherapy within 8 days of initiating treatment in this study
boolean
ID.9
Item
prior autologous or allogeneic transplantation (except as enrolled into this study)
boolean
ID.10
Item
uncontrolled bacterial, viral, fungal or parasitic infections
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial